GSK 343

Product Name:

GSK 343 is a chemical compound developed by GlaxoSmithKline (GSK) as a potent and selective EZH2 inhibitor. It is primarily used in research settings to study the inhibition of EZH2, a protein associated with certain types of cancer.

Product Type:

Chemical – EZH2 Inhibitor

Manufacturing Country:

Multiple countries

Brand Information:

• Brand Name: GSK 343

• Country of Origin: United Kingdom

• Company of Origin: GlaxoSmithKline

• Ultimate Owner Company: GlaxoSmithKline

• Ultimate Owner Company Details: GlaxoSmithKline is a British multinational pharmaceutical and consumer goods company headquartered in Brentford, England. It is one of the world's largest pharmaceutical companies, focusing on the development and manufacturing of a wide range of medicines and vaccines.

• Ultimate Owner Country: United Kingdom

• Subsidiary Information: None

Explanation:

GSK 343 is a chemical compound developed by GlaxoSmithKline (GSK) as a potent and selective EZH2 inhibitor. It is primarily used in research settings to study the inhibition of EZH2, a protein associated with certain types of cancer. The compound is manufactured in multiple countries, reflecting GSK's global production capabilities. GlaxoSmithKline, headquartered in Brentford, England, is a British multinational pharmaceutical and consumer goods company. As of 2026, GSK remains the ultimate owner of the GSK 343 brand, with no known subsidiaries owning the brand locally.